Standard BioTools Inc.
LAB
$1.21
-$0.03-2.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -120.50M | -87.04M | -93.17M | -78.87M | -72.93M |
| Total Depreciation and Amortization | 18.49M | 14.49M | 15.52M | 15.47M | 18.69M |
| Total Amortization of Deferred Charges | -2.51M | -2.51M | -2.51M | -2.51M | -5.60M |
| Total Other Non-Cash Items | 28.84M | 21.12M | 930.00K | -2.74M | -3.77M |
| Change in Net Operating Assets | -17.19M | -18.27M | -25.17M | -35.75M | -24.34M |
| Cash from Operations | -92.88M | -111.26M | -143.45M | -143.46M | -127.00M |
| Capital Expenditure | -12.58M | -10.69M | -6.42M | -3.11M | -1.76M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.39M | -1.39M | 278.65M | 280.03M | 280.03M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.94M | 21.54M | 40.69M | -2.84M | -23.24M |
| Cash from Investing | 36.97M | 59.72M | 363.17M | 324.33M | 305.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -55.00M | -55.00M | -63.19M | -9.44M | -10.28M |
| Issuance of Common Stock | 901.00K | 593.00K | 665.00K | 561.00K | 573.00K |
| Repurchase of Common Stock | -361.00K | -161.00K | -11.18M | -11.31M | -11.65M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -545.00K | -545.00K | -545.00K |
| Cash from Financing | -54.46M | -82.93M | -102.62M | -49.10M | -50.26M |
| Foreign Exchange rate Adjustments | 470.00K | -318.00K | -696.00K | -199.00K | 62.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.90M | -134.87M | 116.32M | 131.49M | 128.00M |